Over 10% of cardiology practice patients inappropriately take aspirin
the ONA take:
According to a new study published in the Journal of the American College of Cardiology, researchers from Michael E. DeBakey Veterans Affairs Medical Center in Houston, Texas, have found that more than 10% of patients are inappropriately taking aspirin for primary prevention of cardiovascular disease.
For the study, researchers identified over 254,000 patients who were taking aspirin between 2008 and 2013 from the National Cardiovascular Disease Registry Practice Innovation and Clinical Experience (PINNACLE) registry. The researchers used the Framingham risk calculator to assess the 10-year risk of cardiovascular disease of the 68,808 evaluable patients.
The researchers defined inappropriate aspirin use for primary prevention as taking aspirin when a patient's 10-year risk was less than 6%; some guidelines say inappropriate use is less than a 10% risk. Results showed that 11.6% of patients taking aspirin for primary prevention had a 10-year risk of less than 6%.
In addition, when comparing inappropriate aspirin use among different cardiology practices, researchers found that inappropriate use ranged from 0% to 70% in different practices.
The findings suggest that the 10-year cardiovascular disease risk should be calculated for each patient, and the clinician should discuss the risk versus benefit of aspirin use with that patient.
More than 10% of patients are inappropriately taking aspirin for primary prevention of cardiovascular disease.
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Online Learning Modules Improve Exercise Counseling, But Not Participation
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|